e-SPACE Heart Failure 2022

Published: 19 October 2022

  • Views:

    Views Icon 17180
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

e-SPACE Heart Failure 2022 was the third edition of the annual global online conference on heart failure. Bringing together thought-leaders from across the globe and broadcast over three time-zones – Asia, Europe, and the Americas – e-SPACE Heart Failure 2022 optimised geographical reach whilst delivering both global and regional insight.

 

Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Andrew Coats (University of Warwick, Coventry, UK) and Dr Shelley Zieroth (University of Manitoba, Manitoba, CA) lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.

 

For the first time, e-SPACE Heart Failure 2022 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
 

e-SPACE Heart Failure 2022 would like to thank the following sponsors:

Learning Objectives

  • Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
  • Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
  • Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
  • Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
  • Translate the findings of recent studies and guidelines into optimal patient management in the regional contexts

Target Audience

  • Heart Failure Specialists
  • General Cardiologists
  • General Practitioners (GPs)
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

More from this programme

Part 1

Day 1

13 sessions
Plenary Session 1: Implementing the 4 foundational therapies in clinical practice Watch now
Meet the expert: Emerging evidence across the spectrum of heart failure: new insights from the deliver trial (Supported by an educational grant from AstraZeneca) Watch now
Plenary Session 2: Managing your HF patients with comorbidities (part 1) Watch now
Meet the expert: SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Watch now
Meet the expert: Improving exercise capacity and quality of life in patients with heart failure – the role of intravenous iron therapy (Supported by an unrestricted educational grant from CSL Vifor) Watch now
Plenary Session 3: Using SGLT2 in your patients: practical considerations Watch now
Satellite Symposium: SGLT2 inhibition as foundational heart failure therapy: have we changed our practices? (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Watch now
Plenary Session 4: Managing your HF patients with comorbidities (part 2) Watch now
Meet the expert: Best practice recommendations for the management of hyperkalemia (Supported by an educational grant from AstraZeneca) Watch now
Meet the expert: Hyperkalaemia in patients with heart failure – dreadful side effect or manageable condition? (Supported by an unrestricted educational grant from CSL Vifor) Watch now
Plenary Session 5: Managing side effects of HF drugs Watch now
Meet the expert: Sex differences in advanced heart failure Watch now
Plenary Session 6: How to manage the obese patient with HF Watch now

Faculty Biographies

Stephen J Greene

Stephen J Greene

Assistant Professor, Advanced Heart Failure & Transplantation

Dr Stephen Greene is Assistant Professor in Advanced Heart Failure & Transplantation at The Duke University School of Medicine in Durham, North Carolina, US. 

Dr Greene is a cardiologist with a clinical and research interest in heart failure. His research interests are focused on strategies and therapies to improve outcomes and quality of life for patients with heart failure. This involves research through clinical trials and through examining data from real-world clinical practice.

View full profile
Mitja Lainscak

Mitja Lainscak

Professor, Division of Cardiology

Prof Mitja Lainscak is a Professor in the Division of Cardiology at University of Ljubljana, Ljubljana, SI. He is also Director of the Slovenian Research Agency.

 

 

View full profile
Gregg Stone

Gregg Stone

Professor of Medicine, Professor of Population Health Sciences and Policy, and Director of Academic Affairs

Dr Stone is a leading expert in interventional cardiology and is one of the most widely cited researchers in science. He has served as the principal investigator for approximately 130 national and international multicentre randomised trials, has delivered thousands of lectures internationally, and has authored more than 2,500 book chapters, manuscripts and abstracts published in peer-reviewed literature.

Dr Stone is the Director of Academic Affairs for Mount Sinai Heart Health System, and Professor of Medicine and Professor of Population Health Sciences and Policy at The Zena and Michael A Wiener Cardiovascular Institute, Icahn School of Medicine, at Mount Sinai, New York.

Dr Gregg Stone is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).

View full profile
Horst Sievert

Horst Sievert

Director

Dr Horst Sievert, MD, is the Director of the CardioVascular Center Frankfurt, Sankt Katharinen, and the Department of Internal Medicine, Cardiology, and Vascular Medicine of the Sankt Katharinen Hospital in Frankfurt, Germany. 

Dr Sievert is also an Associate Professor of Internal Medicine/Cardiology at the University of Frankfurt. Dr Sievert became Director of the Department of Interventional Cardiology and Angiology of the Heart Center Rotenburg in 1990, Senior Consultant at the Bethanien Hospital in Frankfurt in 1993, and Director of the CardioVascular Center Frankfurt, Sankt Katharinen in 2003. He has been the principal investigator in a number of clinical trials and has authored more than 130 manuscripts and 500 abstracts in peer-reviewed journals and 50 books and book contributions. 

View full profile
Harish Ramakrishna

Harish Ramakrishna

View full profile
Ralph von Bardeleben

Ralph von Bardeleben

Head of the Centre of Structural Heart Disease Interventions and the Heart Valve Centre

Prof Ralph Stephan von Bardeleben is the Head of the Center of Structural Heart Disease Interventions and the Heart Valve Center in Mainz, Germany 

Prof Bardeleben is Past-President of the German working group on Echocardiography of the German Society of Cardiology and a member of several medical societies. He serves on the Clinical Program commission and at your region program of the ESC and is a reviewer for several peer-reviewed journals. Newly elected co-editor-in-chief of Echocardiography Journal.

He participates as PI, steering committee member and core laboratory in several medical device trials, including a German Federal Institute for Drugs and Medical Devices (BfArM)-approved first- or early-in-human medical device implant trials.

View full profile